Search research articles
Contact Us
Filters
Showing results (1-10 of 207) with videos related to
Page
of 21
Sort By:
Geburtshilfe Und Frauenheilkunde
|
December 27, 2019
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Nina Ditsch, Marcus Schmidt
Expert Review of Anticancer Therapy
|
June 25, 2003
Immunotherapy: new options in breast cancer treatment
Michael Untch, Nina Ditsch, Kerstin Hermelink
Current Opinion in Obstetrics & Gynecology
|
January 3, 2023
Recommendations for the diagnosis and treatment of patients with early breast cancer: update 2023
Melitta M Köpke, Bahriye Aktas, Nina Ditsch
Breast Care (Basel, Switzerland)
|
June 23, 2025
St. Gallen/Vienna 2025 Summary of Key Messages on Therapy in Early Breast Cancer from the 2025 St. Gallen International Breast Cancer Conference
Nina Ditsch, Michael Gnant, Christoph Thomssen, et al.
Breast Care (Basel, Switzerland)
|
August 26, 2024
ASCO 2024: Personal Insights and a Look into the Future from an International Expert Group
Mattea Reinisch, Paolo Tarantino, Nina Ditsch, et al.
Deutsches Arzteblatt International
|
June 4, 2011
Hereditary breast and ovarian cancer: new genes, new treatments, new concepts
Alfons Meindl, Nina Ditsch, Karin Kast, et al.
Journal of Cancer Research and Clinical Oncology
|
March 4, 2016
p53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer
Sabine Heublein, Sabina K Page, Doris Mayr, et al.
Archives of Gynecology and Obstetrics
|
October 30, 2012
Thyroid (dys-)function in normal and disturbed pregnancy
Brigitte K Budenhofer, Nina Ditsch, Udo Jeschke, et al.
Archives of Gynecology and Obstetrics
|
July 18, 2013
Work-life balance of German gynecologists: a web-based survey on satisfaction with work and private life
Katharina Hancke, Wilmar Igl, Bettina Toth, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
April 22, 2017
Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis
Sabine Heublein, Doris Mayr, Alfons Meindl, et al.
Page
of 21
Search research articles
Search
Showing results (1-10 of 207) with videos related to
Sort By:
Page
of 21
Geburtshilfe Und Frauenheilkunde
|
December 27, 2019
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Nina Ditsch, Marcus Schmidt
Expert Review of Anticancer Therapy
|
June 25, 2003
Immunotherapy: new options in breast cancer treatment
Michael Untch, Nina Ditsch, Kerstin Hermelink
Current Opinion in Obstetrics & Gynecology
|
January 3, 2023
Recommendations for the diagnosis and treatment of patients with early breast cancer: update 2023
Melitta M Köpke, Bahriye Aktas, Nina Ditsch
Breast Care (Basel, Switzerland)
|
June 23, 2025
St. Gallen/Vienna 2025 Summary of Key Messages on Therapy in Early Breast Cancer from the 2025 St. Gallen International Breast Cancer Conference
Nina Ditsch, Michael Gnant, Christoph Thomssen, et al.
Breast Care (Basel, Switzerland)
|
August 26, 2024
ASCO 2024: Personal Insights and a Look into the Future from an International Expert Group
Mattea Reinisch, Paolo Tarantino, Nina Ditsch, et al.
Deutsches Arzteblatt International
|
June 4, 2011
Hereditary breast and ovarian cancer: new genes, new treatments, new concepts
Alfons Meindl, Nina Ditsch, Karin Kast, et al.
Journal of Cancer Research and Clinical Oncology
|
March 4, 2016
p53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer
Sabine Heublein, Sabina K Page, Doris Mayr, et al.
Archives of Gynecology and Obstetrics
|
October 30, 2012
Thyroid (dys-)function in normal and disturbed pregnancy
Brigitte K Budenhofer, Nina Ditsch, Udo Jeschke, et al.
Archives of Gynecology and Obstetrics
|
July 18, 2013
Work-life balance of German gynecologists: a web-based survey on satisfaction with work and private life
Katharina Hancke, Wilmar Igl, Bettina Toth, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
April 22, 2017
Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis
Sabine Heublein, Doris Mayr, Alfons Meindl, et al.
Page
of 21